Results 211 to 220 of about 572,905 (336)
Combined IVIg and 500 mg/day IVMP achieve superior efficacy over monotherapies in anti‐LGI1 encephalitis, with optimal safety. Higher‐dose IVMP (1000 mg) accelerates response but increases adverse events, particularly in diabetic patients. Cognitive deficits persist post‐treatment, necessitating long‐term management.
Yao Tan +6 more
wiley +1 more source
Sex-Specific Differences in Gut Microbiota Composition in Adult Patients with Bronchial Asthma. [PDF]
Hirano C +11 more
europepmc +1 more source
This is the first study on novel furochromene derivatives. A series of novel furochromen derivatives, namely (2E)‐1‐(6‐hydroxy‐4,7‐dimethoxy‐1‐benzofuran‐5‐yl)‐3‐arylprop‐2‐en‐1‐ones 4a–c, were synthesized via the Knoevenagel condensation of 6‐hydroxy‐4,7‐dimethoxybenzofuran‐5‐ylethanone 2 with various aromatic aldehydes.
Amal Rabahi +9 more
wiley +1 more source
Tracheobronchial Tuberculosis During Treatment for Bronchial Asthma. [PDF]
Sakai H +5 more
europepmc +1 more source
Pretreatment with New Zealand blackcurrant anthocyanins nonsignificantly reduced TNF‐α–induced PAI‐1 release in bronchial epithelial cells. The small sample size may have influenced the lack of statistical significance. This study provides preliminary evidence of possible effects of NZBC anthocyanins on PAI‐1 secretion but warrants further extensive ...
Madiha Ajaz +5 more
wiley +1 more source
Osteoarthritis, bronchial asthma, and periodontitis: is there a mutual influence? A 5-year case-control study. [PDF]
Semaan LB +6 more
europepmc +1 more source
We describe a case of complete right upper lobe atelectasis caused by an endobronchial hamartoma that was initially misdiagnosed on flexible bronchoscopic biopsy and was successfully treated with rigid bronchoscopy and laser therapy. ABSTRACT Endobronchial hamartomas are very rare benign lung tumours that may cause airway obstruction and are frequently
Meridiana Dodaj +4 more
wiley +1 more source
Impact of severity of bronchial asthma on oral health in children. [PDF]
Alrashdi M, Alyahya A.
europepmc +1 more source
ABSTRACT Chronic obstructive pulmonary disease (COPD) remains the third leading cause of death worldwide, and conventional bronchodilator‐based therapies have limited efficacy in preventing exacerbations and disease progression. The 2024–2026 period represents a historic inflection point: three mechanistically distinct agents received Food and Drug ...
Naoya Fujino, Hisatoshi Sugiura
wiley +1 more source
Efficacy of synergistic nursing and flexible play-based approach in children with Bronchial Asthma. [PDF]
Guo Q, Li B, Hu Y, Liu L, Lv W.
europepmc +1 more source

